Literature DB >> 11874583

Do AV fistulas contribute to cardiac mortality in hemodialysis patients?

Ralf Dikow1, Vedat Schwenger, Martin Zeier, Eberhard Ritz.   

Abstract

Potential fistula-related problems which may impact on patient survival include high fistula flow with hyperkinetic circulation and cardiac failure, low fistula flow with the risks of underdialysis and fistula thrombosis, vascular access infection with local or systemic manifestations, and possibly induction and maintenance of a microinflammatory state (at least for synthetic grafts). All these complications are much more common with prosthetic grafts than with native arteriovenous (AV) fistulas. Fistula flow should be monitored (e.g., by duplex sonography) to guarantee adequate flow and permit preemptive intervention to avoid fistula thrombosis.

Entities:  

Mesh:

Year:  2002        PMID: 11874583     DOI: 10.1046/j.1525-139x.2002.00003.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  12 in total

1.  Treatment of arteriovenous shunts after renal transplantation.

Authors:  Hidehisa Kitada; Atsushi Sugitani; Yasuhiro Okabe; Atsushi Doi; Yasunobu Nishioka; Takehiro Nishiki; Tadashi Kayashima; Reiko Tanabe; Masao Tanaka
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

2.  Acute liver failure following hemodialysis arteriovenous graft placement: a case report.

Authors:  Zachary Z Brener; Augusto D Paiusco; Michael Bergman
Journal:  J Med Case Rep       Date:  2010-08-10

3.  Relation between access blood flow and mortality in chronic hemodialysis patients.

Authors:  Mohammed Al-Ghonaim; Braden J Manns; David J Hirsch; Zhiwei Gao; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

4.  Association of dialysis modality and cardiovascular mortality in incident dialysis patients.

Authors:  David W Johnson; Hannah Dent; Carmel M Hawley; Stephen P McDonald; Johan B Rosman; Fiona G Brown; Kym Bannister; Kathryn J Wiggins
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 8.237

5.  Can losartan and blood pressure control peri arteriovenous fistula creation ameliorate the early associated left ventricular hypertrophic response a randomised placebo controlled trial.

Authors:  Dominica Zentner; Eugenie Pedagogos; Anthony Yapanis; Sofie Karapanagiotidis; Alison Kinghorn; Athanasia Alexiou; Geoffrey Lee; Matija Raspudic; Anuradha Aggarwal
Journal:  BMC Res Notes       Date:  2012-05-29

6.  Early follow-up results of arteriovenous fistulae created for hemodialysis.

Authors:  Hikmet Iyem
Journal:  Vasc Health Risk Manag       Date:  2011-05-19

7.  Surveillance and monitoring of dialysis access.

Authors:  Lalathaksha Kumbar; Jariatul Karim; Anatole Besarab
Journal:  Int J Nephrol       Date:  2011-11-22

8.  Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis: A Population-Based Nested Case-Control Study.

Authors:  Te-Hui Kuo; Chien-Tzu Tseng; Wei-Hung Lin; Jo-Yen Chao; Wei-Ming Wang; Chung-Yi Li; Ming-Cheng Wang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Kai-Uwe Eckardt; Nisha Bansal; Josef Coresh; Marie Evans; Morgan E Grams; Charles A Herzog; Matthew T James; Hiddo J L Heerspink; Carol A Pollock; Paul E Stevens; Manjula Kurella Tamura; Marcello A Tonelli; David C Wheeler; Wolfgang C Winkelmayer; Michael Cheung; Brenda R Hemmelgarn
Journal:  Kidney Int       Date:  2018-04-12       Impact factor: 10.612

10.  Comparing Survival between peritoneal dialysis and hemodialysis patients with subclinical peripheral artery disease: a 6-year follow-up.

Authors:  Jiung-Hsiun Liu; Jan-Yow Chen; Shih-Yi Lin; Hsin-Hung Lin; I-Wen Ting; Chih-Chia Liang; I-Kuan Wang; Huey-Liang Kuo; Chiz-Tzung Chang; Chiu-Ching Huang; Fung-Chang Sung
Journal:  Int J Med Sci       Date:  2013-03-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.